Checkpoint Therapeutics Statistics Share Statistics Checkpoint Therapeutics has 86.32M
shares outstanding. The number of shares has increased by 94.78%
in one year.
Shares Outstanding 86.32M Shares Change (YoY) 94.78% Shares Change (QoQ) 79.34% Owned by Institutions (%) 43.4% Shares Floating 66.45M Failed to Deliver (FTD) Shares 8,296 FTD / Avg. Volume 0.27%
Short Selling Information The latest short interest is 697.5K, so 0% of the outstanding
shares have been sold short.
Short Interest 697.5K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.26 and the forward
PE ratio is 3.77.
Checkpoint Therapeutics's PEG ratio is
0.05.
PE Ratio -2.26 Forward PE 3.77 PS Ratio 3096.54 Forward PS 2 PB Ratio -10.06 P/FCF Ratio -4.08 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Checkpoint Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.37,
with a Debt / Equity ratio of 0.
Current Ratio 0.37 Quick Ratio 0.37 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.71K Profits Per Employee $-2.34M Employee Count 24 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 84.42% in the
last 52 weeks. The beta is 1.14, so Checkpoint Therapeutics's
price volatility has been higher than the market average.
Beta 1.14 52-Week Price Change 84.42% 50-Day Moving Average 4.09 200-Day Moving Average 3.33 Relative Strength Index (RSI) 79.34 Average Volume (20 Days) 3,078,214
Income Statement In the last 12 months, Checkpoint Therapeutics had revenue of 41K
and earned -56.24M
in profits. Earnings per share was -1.42.
Revenue 41K Gross Profit 41K Operating Income -56.17M Net Income -56.24M EBITDA -56.17M EBIT -56.17M Earnings Per Share (EPS) -1.42
Full Income Statement Balance Sheet The company has 6.6M in cash and 0 in
debt, giving a net cash position of 6.6M.
Cash & Cash Equivalents 6.6M Total Debt n/a Net Cash n/a Retained Earnings -370.57M Total Assets 34.16M Working Capital 16.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -31.1M
and capital expenditures 0, giving a free cash flow of -31.1M.
Operating Cash Flow -31.1M Capital Expenditures n/a Free Cash Flow -31.1M FCF Per Share -0.78
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -137009.76% and -137170.73%.
Gross Margin 100% Operating Margin -137009.76% Pretax Margin -137170.73% Profit Margin -137170.73% EBITDA Margin -137009.76% EBIT Margin -137009.76% FCF Margin -75856.1%
Dividends & Yields CKPT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CKPT is $4.1,
which is -3.8% lower than the current price. The consensus rating is "Hold".
Price Target $4.1 Price Target Difference -3.8% Analyst Consensus Hold Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 6, 2022. It was a
backward
split with a ratio of 1:10.
Last Split Date Dec 6, 2022 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -8.17 Piotroski F-Score 3
